3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Colorectal Neoplasms
5
Medulloblastoma
3
Colonic Neoplasms
3
Turcot syndrome
2
Triple Negative Breast Neoplasms
2
Rhabdoid Tumor
2
Recurrence
2
Pinealoma
2
Neuroblastoma
2
Ependymoma
2
Carcinoma
2
Urinary Bladder Neoplasms
1
Solid Tumor
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Pancreatic Cancer Metastatic
1
Ovarian Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasms
1
Mouth Neoplasms
1
Melanoma
1
Locally Advanced Rectal Cancer
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
Gemcitabine
16
Mitomycin
10
Docetaxel
6
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Celecoxib
×
1 year
×
Clear all
No trials found.